SPRAVATO

Class [005]
Human pharmaceuticals for the prevention and treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases including pulmonary hypertension and idiopathic pulmonary fibrosis; human pharmaceuticals for the prevention and treatment of auto-immune diseases, namely anti-allergy medications; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of central nervous system diseases, namely pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of central nervous system diseases, namely pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, depression, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis and digital ulcers; anti-viral medications; anti-inflammatory medications; anti-pain medications; anti-infective medications.